News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
786,842 Results
Type
Article (57064)
Company Profile (317)
Press Release (729444)
Multimedia
Podcasts (174)
Webinars (27)
Section
Business (217611)
Career Advice (2900)
Deals (37778)
Drug Delivery (158)
Drug Development (86868)
Employer Resources (191)
FDA (17948)
Job Trends (16049)
News (371527)
Policy (37027)
Tag
2027 BioCapital Elite (1)
2027 BioMidwest Elite (1)
2027 Biotech Bay Standard (2)
2027 Biotech Beach Elite (1)
2027 Genetown Elite (3)
2027 Pharm Country Elite (1)
2027 Pharm Country Standard (3)
Academia (2895)
Academic (1)
Accelerated approval (45)
Adcomms (37)
Allergies (172)
Alliances (53279)
ALS (206)
Alzheimer's disease (1872)
Antibody-drug conjugate (ADC) (406)
Approvals (18170)
Artificial intelligence (661)
Autoimmune disease (245)
Automation (52)
Bankruptcy (395)
Best Places to Work (12103)
BIOSECURE Act (23)
Biosimilars (217)
Biotechnology (204)
Bladder cancer (185)
Brain cancer (70)
Breast cancer (714)
Cancer (5571)
Cardiovascular disease (500)
Career advice (2455)
Career pathing (45)
CAR-T (324)
CDC (71)
Celiac Disease (2)
Cell therapy (873)
Cervical cancer (42)
Clinical research (74307)
Collaboration (2031)
Company closure (6)
Compensation (1300)
Complete response letters (90)
COVID-19 (2983)
CRISPR (109)
C-suite (1036)
Cystic fibrosis (159)
Data (7193)
Decentralized trials (3)
Denatured (50)
Depression (174)
Dermatology (59)
Diabetes (587)
Diagnostics (7164)
Digital health (51)
Diversity (12)
Diversity, equity & inclusion (47)
Drug discovery (323)
Drug pricing (234)
Drug shortages (35)
Duchenne muscular dystrophy (285)
Earnings (94685)
Editorial (71)
Employer branding (22)
Employer resources (163)
Events (126178)
Executive appointments (1096)
FDA (21475)
Fibrodysplasia Ossificans Progressiva (7)
Friedreich's ataxia (14)
Frontotemporal dementia (30)
Funding (1685)
Gene editing (233)
Generative AI (56)
Gene therapy (729)
GLP-1 (1194)
Government (5225)
Grass and pollen (8)
Guidances (399)
Healthcare (20009)
HIV (79)
Huntington's disease (58)
IgA nephropathy (96)
Immunology and inflammation (327)
Immuno-oncology (90)
Indications (158)
Infectious disease (3326)
Inflammatory bowel disease (220)
Inflation Reduction Act (15)
Influenza (136)
Intellectual property (283)
Interviews (528)
IPO (17338)
IRA (58)
Job creations (4272)
Job search strategy (2015)
JPM (71)
Kidney cancer (19)
Labor market (99)
Layoffs (655)
Leadership (44)
Legal (9263)
Liver cancer (105)
Longevity (28)
Lung cancer (753)
Lymphoma (414)
Machine learning (53)
Management (64)
Manufacturing (978)
MASH (193)
Medical device (14645)
Medtech (14725)
Mergers & acquisitions (21614)
Metabolic disorders (1578)
mRNA (210)
Multiple sclerosis (181)
NASH (24)
Neurodegenerative disease (432)
Neuropsychiatric disorders (115)
Neuroscience (3384)
Neurotech (2)
NextGen: Class of 2026 (7052)
Non-profit (4833)
Now hiring (74)
Obesity (774)
Opinion (326)
Ovarian cancer (190)
Pain (243)
Pancreatic cancer (262)
Parkinson's disease (363)
Partnered (33)
Patents (579)
Patient recruitment (613)
Peanut (65)
People (63427)
Pharmaceutical (70)
Pharmacy benefit managers (35)
Phase 1 (23069)
Phase 2 (32492)
Phase 3 (24495)
Pipeline (7275)
Policy (363)
Postmarket research (2954)
Preclinical (9879)
Press Release (69)
Prostate cancer (290)
Psychedelics (61)
Radiopharmaceuticals (321)
Rare diseases (1107)
Real estate (6600)
Recruiting (74)
Regulatory (27809)
Reports (61)
Research institute (2644)
Resumes & cover letters (477)
Rett syndrome (33)
RNA editing (21)
RSV (95)
Schizophrenia (178)
Series A (285)
Series B (208)
Service/supplier (14)
Sickle cell disease (115)
Special edition (29)
Spinal muscular atrophy (179)
Sponsored (52)
Startups (3989)
State (2)
Stomach cancer (21)
Supply chain (124)
Tariffs (101)
The Weekly (121)
Vaccines (1212)
Venture capital (111)
Weight loss (526)
Women's health (112)
Worklife (23)
Date
Today (155)
Last 7 days (753)
Last 30 days (2877)
Last 365 days (31668)
2026 (8362)
2025 (31957)
2024 (36895)
2023 (41761)
2022 (53091)
2021 (57708)
2020 (56282)
2019 (49220)
2018 (37247)
2017 (34902)
2016 (35155)
2015 (40955)
2014 (35142)
2013 (30037)
2012 (32265)
2011 (32846)
2010 (31009)
Location
Africa (931)
Alabama (95)
Alaska (7)
Arizona (349)
Arkansas (14)
Asia (44538)
Australia (7391)
California (12602)
Canada (3543)
China (1301)
Colorado (534)
Connecticut (548)
Delaware (377)
Europe (100332)
Florida (1891)
Georgia (406)
Hawaii (4)
Idaho (66)
Illinois (1009)
India (82)
Indiana (575)
Iowa (23)
Japan (500)
Kansas (131)
Kentucky (46)
Louisiana (40)
Maine (84)
Maryland (1544)
Massachusetts (9100)
Michigan (365)
Minnesota (701)
Mississippi (7)
Missouri (150)
Montana (34)
Nebraska (30)
Nevada (138)
New Hampshire (85)
New Jersey (3407)
New Mexico (30)
New York (3335)
North Carolina (1672)
North Dakota (10)
Northern California (6194)
Ohio (384)
Oklahoma (24)
Oregon (45)
Pennsylvania (2525)
Puerto Rico (26)
Rhode Island (50)
South America (1346)
South Carolina (78)
South Dakota (1)
Southern California (4951)
Tennessee (203)
Texas (1979)
United States (44961)
Utah (375)
Vermont (1)
Virginia (306)
Washington D.C. (86)
Washington State (1017)
West Virginia (4)
Wisconsin (136)
Wyoming (2)
786,842 Results for "canon u s a inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Quanta System Inc.: Strengthening the U.S. Presence of Italian Laser Technology
March 1, 2026
·
4 min read
Press Releases
PANTHERx® Rare Selected by Rhythm Pharmaceuticals Inc. as the Exclusive U.S. Specialty Pharmacy for the Expanded Indication for IMCIVREE® (setmelanotide)
March 22, 2026
·
4 min read
Press Releases
Vivos Inc. Diversifies Manufacturing Base with Planned U.S. and International Production Sites
February 17, 2026
·
2 min read
Press Releases
FibroBiologics, Inc. Announces Issuance of U.S. Patent Covering Fibroblast Cell Therapy for the Treatment of Osteoporosis
March 2, 2026
·
5 min read
Job Trends
Report: 2026 U.S. Life Sciences Salary Report
BioSpace
‘s 2026 U.S. Life Sciences Salary Report delivers a comprehensive look at how salaries, bonuses and benefits evolved over the past year amid ongoing economic pressure and workforce recalibration. It uncovers not just what people are earning, but how they’re thinking about compensation, career moves and total rewards in 2026.
March 19, 2026
·
1 min read
·
BioSpace Insights
Press Releases
OS Therapies Granted Meetings with U.S. FDA, U.K. MHRA, EMA and Australian Therapeutic Goods Administration to Review Global Confirmatory Phase 3 Trial for OST-HER2 in Metastatic Osteosarcoma
• Meetings with all four regulatory agencies scheduled to occur in the second quarter of 2026, with expected Phase 3 commencement in the third quarter of 2026 initially in Australia • Commencing the Phase 3 confirmatory study is a pre-requisite to being granted a Biologics License Application (BLA) under the Accelerated Approval Program in the U.S. and Conditional Marketing Authorisations (CMAs) in the U.K. & Europe
March 27, 2026
·
5 min read
Press Releases
Zydus Lifesciences Limited completes the acquisition of Agenus Inc.'s biologics manufacturing facilities, launches Zylidac Bio LLC in the U.S.
January 16, 2026
·
3 min read
Press Releases
MEDIPOST Inc. Submits IND Amendment With U.S. Food and Drug Administration to Initiate Phase III Trial
February 13, 2026
·
1 min read
Press Releases
Arna Pharma Inc. and Slate Run Pharmaceuticals to form a Joint Venture to Create Scaled-Up U.S. Specialty Pharmaceutical Platform
February 26, 2026
·
3 min read
Press Releases
Vivos Inc. Strengthens Patent Protection with New U.S. Patent Issuance and PRECISIONGEL™ Trademark Approvals
January 29, 2026
·
2 min read
1 of 78,685
Next
